Combination of quantitative capnometry, N-terminal pro-brain natriuretic peptide, and clinical assessment in differentiating acute heart failure from pulmonary disease as cause of acute dyspnea in pre-hospital Emergency setting: Study of diagnostic accuracy

Croatian Medical Journal

Volumn 50, Issue 2, 2009, Pages 133-142

  Klemen, Petra ^a,b   Golub, Mirjam ^a   Grmec, Štefek ^a,c  

^a Center for Emergency Medicine   (Slovenia)

^b UNIVERSITY OF MARIBOR   (Slovenia)

^c UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO BRAIN NATRIURETIC PEPTIDE (1 76); PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ACUTE HEART FAILURE; ADULT; AGED; APNEA; ARTICLE; ASTHMA; CAPNOGRAPHY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DYSPNEA; EMERGENCY CARE; FEMALE; HUMAN; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; QUANTITATIVE DIAGNOSIS; SENSITIVITY AND SPECIFICITY; SLOVENIA; ACUTE DISEASE; ANALYSIS OF VARIANCE; BLOOD; COHORT ANALYSIS; COMPARATIVE STUDY; CONFIDENCE INTERVAL; DIFFERENTIAL DIAGNOSIS; EMERGENCY; EMERGENCY HEALTH SERVICE; HEART FAILURE; METHODOLOGY; PHYSICAL EXAMINATION; PROBABILITY; RISK; RISK ASSESSMENT; TOTAL QUALITY MANAGEMENT;

ACUTE DISEASE; ANALYSIS OF VARIANCE; CAPNOGRAPHY; COHORT STUDIES; CONFIDENCE INTERVALS; DIAGNOSIS, DIFFERENTIAL; DYSPNEA; EMERGENCIES; EMERGENCY MEDICAL SERVICES; FEMALE; HEART FAILURE; HUMANS; LUNG DISEASES; MALE; NATRIURETIC PEPTIDE, BRAIN; ODDS RATIO; PEPTIDE FRAGMENTS; PHYSICAL EXAMINATION; PROBABILITY; PROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TOTAL QUALITY MANAGEMENT;

EID: 67651011672     PISSN: 03539504     EISSN: 13328166     Source Type: Journal    
DOI: 10.3325/cmj.2009.50.133     Document Type: Article

References (31)

1. Stevenson LW, Perlof JK. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA. 1989; 261: 884-8. Medline:2913385 doi:10.1001/jama.261.6.884 (Pubitemid 19046417)
2. Remes J, Miettinen H, Reunanen A, Pyorala K. Validity of clinical diagnosis of heart failure in primary health care. Eur heart J. 1991; 12: 315-21. Medline:2040313
3. Mulrow CD, Lucey CR, Farnett LE. Discriminating causes of dyspnea through clinical examination. J Gen Intern Med. 1993; 8: 383-92. Medline:8410400 doi:10.1007/bF02600079
4. Wuerz RC, Meador SA. Effects of prehospital medications on mortality and length of stay in congestive heart failure. Ann emerg Med. 1992; 21: 669-74. Medline:1590605 doi:10.1016/S0196-0644 (05) 82777-5
5. Stiell IG, Spaite DW, Field B, Nesbitt LP, Munkley D, Maloney J, et al. Advanced life support for out-of-hospital respiratory distress. N Engl J Med. 2007; 356: 2156-64. Medline:17522399 doi:10.1056/nej-Moa060334
6. Livigni S, Maio M, Ferretti E, longobardo A, Potenza R, Rivalta l, et al. Efcacy and safety of a low-flow veno-venous carbon dioxide removal device: results of an experimental study in adult sheep. Crit Care. 2006; 10: R151. Medline:17069660 doi:10.1186/cc5082 (Pubitemid 47086942)
7. Maisel AS, Krishnaswamy P, Nowak RM, Mccord J, Hollander JE, Duc P, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002; 347: 161-7. Medline:12124404 doi:10.1056/nejMoa020233 (Pubitemid 34764819)
8. Januzzi JL Jr, Camargo CA, Anwaruddin S, Baggish AL, Chen AA, Krauser DG, et al. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol. 2005; 95: 948-54. Medline:15820160 doi:10.1016/j.amjcard.2004.12.032 (Pubitemid 40487743)
9. Mueller C, Laule-Kilian K, Frana B, Rodriguez D, Scholer A, Schindler C, et al. Use of B-type natriuretic peptide in the management of acute dyspnea in patients with pulmonary disease. Am heart J. 2006; 151: 471-7. Medline:16442916 doi:10.1016/j.ahj.2005.03.036 (Pubitemid 43144752)
10. Baggish AL, Siebert U, Lainchbury JG, Cameron R, Anwaruddin S, Chen A, et al. A validated clinical and biochemical score for the diagnosis of acute heart failure: the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Acute Heart Failure Score. Am Heart J. 2006; 151: 48-54. Medline:16368291 doi:10.1016/j.ahj.2005.02.031 (Pubitemid 41815330)
11. Brown LH, Gough JE, Seim RH. Can quantitative capnometry differentiate between cardiac and obstructive causes of respiratory distress? Chest. 1998; 113: 323-6. Medline:9498946 doi:10.1378/chest.113.2.323
12. Grmec Š, Golub M, Klemen P, Cander D. Utility of the quantitative capnometry (QC) and rapid bedside test for N-terminal pro-brain natriuretic peptide (pro-BNP) in the evaluation of respiratory distress in prehospital setting - preliminary results. J Emerg Med. 2007; 33: 322. doi:10.1016/j. jemermed.2007.08.009
13. Remes J, Miettinen H, Reunanen A, Pyorala K. Validity of clinical diagnosis of heart failure in primary health care. Eur heart J. 1991; 12: 315-21. Medline:2040313
14. McKee PA, Castelli W P, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med. 1971; 285: 1441-6. Medline:5122894
15. Papiris S, Kotanidou A, Malagari K, Roussos C. Clinical review: severe asthma. Crit care. 2002; 6: 30-44. Medline:11940264 doi:10.1186/cc1451
16. Chung KF, Godard P, Adelroth E, Ayres J, Barnes N, Barnes P, et al. Difcult/therapy-resistant asthma: the need for an integrated approach to defne clinical phenotypes, evaluate risk factors, understand pathophysiology and fnd novel therapies. ERS task Force on difficult/therapy-Resistant Asthma. European Respiratory Society. Eur Respir J. 1999; 13: 1198-208. Medline:10414427
17. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS; Gold Scientifc committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/Who Global Initiative for chronic obstructive lung disease (Gold) Workshop summary. Am J Respir Crit Care Med. 2001; 163: 1256-76. Medline:11316667
18. McGee SR. Physical examination of venous pressure: a critical review. Am Heart J. 1998; 136: 10-8. Medline:9665212 doi:10.1016/S0002-8703 (98) 70175-9
19. Di Bari M, Pozzi C, Cavallini MC, Innocenti F, Baldereschi G, de Alfieri W, et al. The diagnosis of heart failure in the community. comparative validation of four sets of criteria in unselected older adults: the ICARe dicomano Study. J Am Coll Cardiol. 2004; 44: 1601-8. Medline:15489092 doi:10.1016/j.jacc.2004.07.022 (Pubitemid 39369792)
20. Hanley JA, Mcneil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 1983; 148: 839-43. Medline:6878708
21. Macchia A, Monte S, Romero M, D'Ettorre A, Tognoni G. The prognostic influence of chronic obstructive pulmonary disease in patients hospitalised for chronic heart failure. Eur J Heart Fail. 2007; 9: 942-8. Medline:17627878 doi:10.1016/j.ejheart.2007.06.004 (Pubitemid 47332320)
22. Singer AJ, Emerman C, Char DM, Heywood JT, Kirk JD, Hollander JE, et al. Bronchodilator therapy in acute decompensated heart failure patients without a history of chronic obstructive pulmonary disease. Ann emerg Med. 2008; 51: 25-34. Medline:17949853 doi:10.1016/j.annemergmed.2007.04.005 (Pubitemid 350309450)
23. Morrison LK, Harrison A, Krishnaswamy P, Kazanegra R, Clopton P, Maisel A. Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J Am Coll cardiol. 2002; 39: 202-9. Medline:11788208 doi:10.1016/S0735-1097 (01) 01744-2
24. Grmec S, Lah K, Tusek-bunc K. Diference in end-tidal Co2 between asphyxia cardiac arrest and ventricular fibrillation/pulseless ventricular tachycardia cardiac arrest in the prehospital setting. Crit Care. 2003; 7: R139-44. Medline:14624688 doi:10.1186/cc2369
25. Mally S, Jelatancev A, Grmec S. Efects of epinephrine and vasopressin on end-tidal carbon dioxide tension and mean arterial blood pressure in out-of-hospital cardiopulmonary resuscitation: an observational study. Crit Care. 2007; 11: R39. Medline:17376225 doi:10.1186/cc5726 (Pubitemid 46579178)
26. Arena R, Guazzi M, Myers J. Prognostic value of end-tidal carbon dioxide during exercise testing in heart failure. Int J cardiol. 2007; 117: 103-8. Medline:16843545 doi:10.1016/j.ijcard.2006.04.058 (Pubitemid 46399975)
27. Arena R, Peberdy MA, Myers J, Guazzi M, Tevald M. Prognostic value of resting end-tidal carbon dioxide in patients with heart failure. Int J Cardiol. 2006; 109: 351-8. Medline:16046017 doi:10.1016/j.ijcard.2005.06.032
28. Matsumoto A, Itoh H, Eto Y, Kobayashi T, Kato M, Omata M, et al. End-tidal CO2 pressure decreases during exercise in cardiac patients: association with severity of heart failure and cardiac output reserve. J Am Coll cardiol. 2000; 36: 242-9. Medline:10898441 doi:10.1016/S0735-1097 (00) 00702-6
29. Tung RH, Camargo Ca Jr, Krauser D, Anwaruddin S, Baggish A, Chen A, et al. Amino-terminal pro-brain natriuretic peptide for the diagnosis of acute heart failure in patients with previous obstructive airway disease. Ann Emerg Med. 2006; 48: 66-74. Medline:16781921 doi:10.1016/j.annemergmed.2005.12.022 (Pubitemid 43867056)
30. Mccullough PA, Hollander JE, Nowak RM, Storrow AB, Duc P, Omland T. Uncovering heart failure in patients with a history of pulmonary disease: rationale for the early use of B-type natriuretic peptide in the emergency department. Acad Emerg Med. 2003; 10: 198-204. Medline:12615582 doi:10.1111/j.1553-2712.2003. tb01990.x
31. Stein N, Matz H, Schneeweiss A, Eckmann C, Roth-Isigkeit A, Hüppe M, et al. An evaluation of a transcutaneous and an end-tidal capnometer for noninvasive monitoring of spontaneously breathing patients. Respir care. 2006; 51: 1162-6. Medline:17005062